Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known...
Biokin Pharmaceutical Selects Cryoport’s Temperature-Controlled Solutions for its Pending Phase I and Phase II...
Biokin Pharmaceutical Co. Ltd. a leading pharmaceutical company with operations in China and U.S., and...
2019 Trends to Watch For in the Global Clinical Trials Sector
The industry’s pledge to improve the clinical trial experience for participants and investigative sites is...
Clinerion partners with MEDSOFT on expanding clinical research in Georgia
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical...
Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials
Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and Pfizer Inc have entered into...
CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor...
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved the clinical trial...
Bavarian Nordic Completes Enrollment of First Stage in Chordoma Phase 2 Trial
Bavarian Nordic A/S announced , that the first stage of a Phase 2 study of...
Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer...
AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the...
The importance of biometric functions to improving data quality in Clinical Trials
Reducing the costs associated with clinical trials is one of the pharmaceutical industry’s core challenges....
How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden...
Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial...
